147 related articles for article (PubMed ID: 8784419)
1. Schizostatin, a novel squalene synthase inhibitor produced by the mushroom, Schizophyllum commune. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities.
Tanimoto T; Onodera K; Hosoya T; Takamatsu Y; Kinoshita T; Tago K; Kogen H; Fujioka T; Hamano K; Tsujita Y
J Antibiot (Tokyo); 1996 Jul; 49(7):617-23. PubMed ID: 8784419
[TBL] [Abstract][Full Text] [Related]
2. Schizostatin, a novel squalene synthase inhibitor produced by the mushroom, Schizophyllum commune. II. Structure elucidation and total synthesis.
Kogen H; Tago K; Kaneko S; Hamano K; Onodera K; Haruyama H; Minagawa K; Kinoshita T; Ishikawa T; Tanimoto T; Tsujita Y
J Antibiot (Tokyo); 1996 Jul; 49(7):624-30. PubMed ID: 8784420
[TBL] [Abstract][Full Text] [Related]
3. CJ-13,981 and CJ-13,982, new squalene synthase inhibitors.
Watanabe S; Hirai H; Kambara T; Kojima Y; Nishida H; Sugiura A; Yamauchi Y; Yoshikawa N; Harwood HJ; Huang LH; Kojima N
J Antibiot (Tokyo); 2001 Dec; 54(12):1025-30. PubMed ID: 11858656
[TBL] [Abstract][Full Text] [Related]
4. CP-225,917 and CP-263,114, novel Ras farnesylation inhibitors from an unidentified fungus. I. Taxonomy, fermentation, isolation, and biochemical properties.
Dabrah TT; Harwood HJ; Huang LH; Jankovich ND; Kaneko T; Li JC; Lindsey S; Moshier PM; Subashi TA; Therrien M; Watts PC
J Antibiot (Tokyo); 1997 Jan; 50(1):1-7. PubMed ID: 9066758
[TBL] [Abstract][Full Text] [Related]
5. Bisabosquals, novel squalene synthase inhibitors. I. Taxonomy, fermentation, isolation and biological activities.
Minagawa K; Kouzuki S; Nomura K; Yamaguchi T; Kawamura Y; Matsushima K; Tani H; Ishii K; Tanimoto T; Kamigauchi T
J Antibiot (Tokyo); 2001 Nov; 54(11):890-5. PubMed ID: 11827030
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory activity to protein prenylation and antifungal activity of zaragozic acid D3, a potent inhibitor of squalene synthase produced by the fungus, Mollisia sp. SANK 10294.
Tanimoto T; Ohya S; Tsujita Y
J Antibiot (Tokyo); 1998 Apr; 51(4):428-31. PubMed ID: 9630865
[TBL] [Abstract][Full Text] [Related]
7. The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activity.
Dawson MJ; Farthing JE; Marshall PS; Middleton RF; O'Neill MJ; Shuttleworth A; Stylli C; Tait RM; Taylor PM; Wildman HG
J Antibiot (Tokyo); 1992 May; 45(5):639-47. PubMed ID: 1624366
[TBL] [Abstract][Full Text] [Related]
8. Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase.
Bergstrom JD; Kurtz MM; Rew DJ; Amend AM; Karkas JD; Bostedor RG; Bansal VS; Dufresne C; VanMiddlesworth FL; Hensens OD
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):80-4. PubMed ID: 8419946
[TBL] [Abstract][Full Text] [Related]
9. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase.
Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH
J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381
[TBL] [Abstract][Full Text] [Related]
10. Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
Lingham RB; Silverman KC; Jayasuriya H; Kim BM; Amo SE; Wilson FR; Rew DJ; Schaber MD; Bergstrom JD; Koblan KS; Graham SL; Kohl NE; Gibbs JB; Singh SB
J Med Chem; 1998 Nov; 41(23):4492-501. PubMed ID: 9804689
[TBL] [Abstract][Full Text] [Related]
11. Zaragozic acids D and D2: potent inhibitors of squalene synthase and of Ras farnesyl-protein transferase.
Dufresne C; Wilson KE; Singh SB; Zink DL; Bergstrom JD; Rew D; Polishook JD; Meinz M; Huang L; Silverman KC
J Nat Prod; 1993 Nov; 56(11):1923-9. PubMed ID: 8289063
[TBL] [Abstract][Full Text] [Related]
12. [Inhibitory action of natural compounds of microbial origin on cholesterol metabolism].
Fujioka T
Nihon Yakurigaku Zasshi; 1997 Oct; 110 Suppl 1():75P-80P. PubMed ID: 9503410
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel mammalian squalene synthase inhibitors using a three-dimensional pharmacophore.
Fairlamb IJ; Dickinson JM; O'Connor R; Higson S; Grieveson L; Marin V
Bioorg Med Chem; 2002 Aug; 10(8):2641-56. PubMed ID: 12057653
[TBL] [Abstract][Full Text] [Related]
14. TAN-1813, a novel Ras-farnesyltransferase inhibitor produced by Phoma sp. taxonomy, fermentation, isolation and biological activities in vitro and in vivo.
Ishii T; Hayashi K; Hida T; Yamamoto Y; Nozaki Y
J Antibiot (Tokyo); 2000 Aug; 53(8):765-78. PubMed ID: 11079798
[TBL] [Abstract][Full Text] [Related]
15. Lipid-lowering properties of TAK-475, a squalene synthase inhibitor, in vivo and in vitro.
Nishimoto T; Amano Y; Tozawa R; Ishikawa E; Imura Y; Yukimasa H; Sugiyama Y
Br J Pharmacol; 2003 Jul; 139(5):911-8. PubMed ID: 12839864
[TBL] [Abstract][Full Text] [Related]
16. CJ-15,183, a new inhibitor of squalene synthase produced by a fungus, Aspergillus aculeatus.
Watanabe S; Hirai H; Ishiguro M; Kambara T; Kojima Y; Matsunaga T; Nishida H; Suzuki Y; Sugiura A; Harwood HJ; Huang LH; Kojima N
J Antibiot (Tokyo); 2001 Nov; 54(11):904-10. PubMed ID: 11827032
[TBL] [Abstract][Full Text] [Related]
17. Biological activities of novel zaragozic acids, the potent inhibitors of squalene synthase, produced by the fungus, Mollisia sp. SANK 10294.
Tanimoto T; Hamano K; Onodera K; Hosoya T; Kakusaka M; Hirayama T; Shimada Y; Koga T; Tsujita Y
J Antibiot (Tokyo); 1997 May; 50(5):390-4. PubMed ID: 9207908
[TBL] [Abstract][Full Text] [Related]
18. Different analogues of farnesyl pyrophosphate inhibit squalene synthase and protein:farnesyltransferase to different extents.
Cohen LH; Valentijn AR; Roodenburg L; Van Leeuwen RE; Huisman RH; Lutz RJ; Van der Marel GA; Van Boom JH
Biochem Pharmacol; 1995 Mar; 49(6):839-45. PubMed ID: 7702642
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of squalene synthase of rat liver by novel 3' substituted quinuclidines.
McTaggart F; Brown GR; Davidson RG; Freeman S; Holdgate GA; Mallion KB; Mirrlees DJ; Smith GJ; Ward WH
Biochem Pharmacol; 1996 Jun; 51(11):1477-87. PubMed ID: 8630089
[TBL] [Abstract][Full Text] [Related]
20. 3-(4-chlorophenyl)-2-(4-diethylaminoethoxyphenyl)-A-pentenonitrile monohydrogen citrate and related analogs. Reversible, competitive, first half-reaction squalene synthetase inhibitors.
Harwood HJ; Barbacci-Tobin EG; Petras SF; Lindsey S; Pellarin LD
Biochem Pharmacol; 1997 Mar; 53(6):839-64. PubMed ID: 9113105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
